Melanoma News & Updates - Drugs.com
WEBMelanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years. TUESDAY, Sept. 10, 2024 – For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study published online Sept. 8 in JAMA Dermatology to coincide... 10 Sep 2024 by Drugs.com.
New Melanoma Treatment Vaccine Shows Promise in Trial
WEBDec 15, 2023 · By Robin Foster HealthDay Reporter. FRIDAY, Dec. 15, 2023 -- A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49% less likely to die or have their cancer return after three years than those who were given ...
FDA Approves New Treatment for Advanced Melanoma, Amtagvi
WEBFeb 19, 2024 · “Unresectable, or metastatic, melanoma is an aggressive form of cancer that can be fatal,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an agency news release. “The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T-cell ...
BioNTech Announces Positive Topline Phase 2 Results for mRNA ...
WEBCurrent standard of care includes checkpoint inhibitor therapies that substantially improve the life expectancy of patients with melanoma. 2,3 Despite advances in treatment, a high proportion of patients exhibit resistance to approved therapies, leading to limited options for those who progress on targeted or immunotherapy. 4 The 5-year ...
Efficacy Shown for New Melanoma Therapeutic Vaccine
WEBDec 18, 2023 · By Physician’s Briefing Staff HealthDay Reporter. FRIDAY, Dec. 15, 2023 -- In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer. People with advanced melanomas who received …
Melanoma Risk Increased After Radioactive Iodine Treatment for …
WEBSep 26, 2024 · The researchers found that 45.5 percent of the 174,916 patients with primary thyroid cancer diagnosed from 2000 to 2019 had first-course treatment of some form of radiation. Following thyroid cancer, 865 nonkeratinocyte skin cancers (790 melanoma) were diagnosed; 19.8 percent were located on the skin of the head or neck.
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 …
WEBSep 10, 2024 · From 1990 to 2022, there were 34,800 primary invasive cutaneous melanomas reported in 33,324 individuals younger than 60 years. The researchers found a consistent increase in melanoma incidence among those aged 50 to 59 years. An incidence peak was seen in 2013 to 2015 for those aged 20 to 29, 30 to 39, and 40 to 49 years, followed by stable or ...
Amtagvi Approved by the FDA for Treatment of Advanced …
WEBFeb 20, 2024 · By Physician’s Briefing Staff HealthDay Reporter. TUESDAY, Feb. 20, 2024 -- Amtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer. "The approval of Amtagvi offers hope to those with ...
List of 23 Melanoma Medications Compared - Drugs.com
WEBanti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects. For professionals: AHFS DI Monograph. Expand current row for information about ipilimumab. ipilimumab. 6.0. …
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
WEBOct 2, 2024 · By Elana Gotkine HealthDay Reporter. WEDNESDAY, Oct. 2, 2024 -- Circulating antibodies against cancer-testis antigens (CTAgs) are found in stage I and stage II melanoma plasma samples, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 …